Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

ORKA Relative to the S&P 500

ORKA Relative to the Sector

Seasonal Chart Analysis

Analysis of the ARCA biopharma, Inc. (NASD:ORKA) seasonal charts above shows that a Buy Date of November 15 and a Sell Date of February 3 has resulted in a geometric average return of 0.21% above the benchmark rate of the S&P 500 Total Return Index over the past 17 years. This seasonal timeframe has shown positive results compared to the benchmark in 10 of those periods. This is a fair rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 17 years by an average of 100.21% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Oruka Therapeutics Inc is developing novel biologics designed to set a new standard for the treatment of chronic skin diseases. It is to offer patients suffering from chronic skin diseases like plaque psoriasis.

To download ORKA seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: ORKA